Table 3. Sex differences in the implantation and effectiveness of cardiovascular devices.
| Devicea | Effect | References |
|---|---|---|
| ICD | ||
| F < M ICD implantation | 152-160 | |
| F < M Appropriate ICD shocks | 154, 157 | |
| F < M Reduction in total mortality | 155 | |
| F < M Survival benefit with ICD therapy | 154, 157 | |
| CRT | ||
| F < M CRT implantation | 152, 160-164 | |
| F > M Response to CRT therapy | 161, 162 | |
| F > M Long-term survival | 163, 164 | |
| VADs | ||
| F = M Survivalb | 165 | |
| F < M Need for reoperationb | 165 | |
| F > M Right heart failure following VAD implantationb | 165 | |
| F < M Cardiac transplant following VAD implantation | 167 | |
| F > M Hemorrhagic stroke | 167 | |
| F < M Device lead infection | 167 | |
Abbreviations: CRT, cardiac resynchronization therapy; F, female; ICD, implantable cardiac defibrillator; M, male; VADs, ventricular assist devices.
Patients with acute viral myocarditis